MedPath

Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots

Not Applicable
Not yet recruiting
Conditions
Caregivers
Registration Number
NCT07145723
Lead Sponsor
University of Michigan
Brief Summary

This study is being completed to test an AI therapy chatbot application called Earkick to see whether it is feasible and acceptable in supporting care partners who support individuals living with dementia.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Participants need to be a care partner (informal caregiver) of an individual living with dementia
  • Participant provides emotional, physical, and/or financial support/assistance to the individual with dementia (per protocol)
  • Participants indicate high levels of caregiver burden, confirmed using the 12-item Zarit Burden questionnaire (per protocol)
  • Provide informed consent and read, speak, and understand English
  • Have an Apple smartphone, tablet, or laptop, have access to the internet and text messages, and be willing to use this device as well as internet and text message access for the study, including downloading the AI chatbot app
  • Be willing to complete all study assessments
Exclusion Criteria
  • Professional, paid caregivers
  • Anything that would preclude safe or meaningful participation in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Feasibility and Acceptability as measured by the Feasibility and Acceptability Questionnaire4 weeks and 8 weeks (post intervention)

Feasibility and Acceptability Questionnaire (items are scaled from 1 to 5 to indicate level of agreement, where "1" indicates "strong disagreement" and "5" indicates "strong agreement").

Secondary Outcome Measures
NameTimeMethod
Attrition as measured by the percent of participants completing the study8 weeks
Adherence as measured by the percentage of missing data over the course of the study8 weeks

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

University of Michigan
🇺🇸Ann Arbor, Michigan, United States
Rongqi Bei
Contact
rbei@umich.edu
Mark Newman, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.